IRIDEX MicroPulse® Laser in Vascular Macular Disease
Dr. Stela Vujosevic, Dr. Marco Zarbin, & Dr. Munir Escaf
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Introduction
Dr. Marco Zarbin: The Science, Benefits, and Utility of MicroPulse® Technology
45-Year-Old Hispanic Man: Chronic CSR (6 Months)
MicroPulse: Energy Delivery Paradigm
MicroPulse Laser: Duration Coagulation Area
Subthreshold CW ≠ MicroPulse Laser
MicroPulse Laser: Biological Effects
Low vs. High Density Laser Application
MicroPulse Laser: Increase HSP Production by Increasing Laser Density
MicroPulse High Density Treatment (810 nm) vs. Modified ETDRS (532 nm)
Utility of MicroPulse
Dr. Stela Vujosevic: MicroPulse® Laser Therapy in DME: morphologic and functional safety and efficacy
Subthreshold MicroPulse Laser
DME - Laser Treatment in 2017
Laser Treatment in Randomized Clinical Trials
SMPL vs Conventional L: Meta-Analysis of RC Trials
SMPL vs ETDRS L: Meta-Analysis of RC Trials
ETDRS laser: visible retinal lesions
Subthreshold MPL does not damage retina
Safety of Transfoveal Subthreshold IR-MPL for Fovea-Involving DME in Eyes with good Visual Acuity
SMPL preserves/increases retinal sensitivity
IR vs Yellow MPL: Treatment Parameters
Subthreshold MicroPulse Laser
Subthreshold MicroPulse Laser - Safe and Effective Treatment
Subthreshold MicroPulse Laser in DME
Subthreshold MicroPulse Laser - Safe and Effective Treatment pt 2
Subthreshold MicroPulse Laser - Can be used in combined treatments
Subthreshold MicroPulse Laser - Safe and Effective Treatment pt 3
Subthreshold MicroPulse Laser - Patient Selection
Dr. Munir Escaf: TxCell™-Guided MicroPulse®: safe, effective and immediate care for CSR patients
PURPOSE
METHODS
RESULTS
BCVA - Pre MicroPulse: 20/20 vs. Post Micropulse: 20/25
BCVA - Pre MicroPulse: 20/40 vs. Post Micropulse: 20/25
Control Group Resolution
Control Group
Acute CSR
Resolution Week 4
Conclusion
What makes TxCell guided MicroPulse useful in acute CSR?
577nm TXCELL-GUIDED MICROPULSE TREATMENT TECHNIQUE
PHYSICIAN EXPECTATIONS FOR MICROPULSE LASER THERAPY
More Information
No transcript for this webinar
More Information
Request info